Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) has received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12 month target price among […]
500.com reiterated their reiterates rating on shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) in a research note published on Friday morning, Benzinga reports. A number of other research firms have also recently weighed in on CLSD. HC Wainwright restated a buy rating and issued a $6.00 price target on shares of Clearside Biomedical in […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) was the recipient of a large drop in short interest in April. As of April 15th, there was short interest totalling 269,600 shares, a drop of 19.6% from the March 31st total of 335,500 shares. Currently, 0.5% of the shares of the stock are sold short. Based on […]
Clearside Biomedical, Inc. (NASDAQ:CLSD – Get Rating) saw a significant decline in short interest in April. As of April 15th, there was short interest totalling 269,600 shares, a decline of 19.6% from the March 31st total of 335,500 shares. Currently, 0.5% of the shares of the company are sold short. Based on an average daily […]
StockNews.com lowered shares of Clearside Biomedical (NASDAQ:CLSD – Get Rating) from a hold rating to a sell rating in a research note released on Friday morning. A number of other research firms also recently issued reports on CLSD. JMP Securities reduced their price target on shares of Clearside Biomedical from $7.00 to $6.00 and set […]